The COVID-19 pandemic has shown how vulnerabilities in health systems can have profound implications for health, economic progress, trust in governments, and social cohesion.
Containing and mitigating the spread and infection rate of the virus are essential. But so is strengthening the capacity of health systems to respond swiftly and effectively to public health emergencies.
This page features the latest OECD work on the impact of COVID-19 on health and health systems, along with OECD recommendations and policy advice on how to boost health systems’ resiliency. It also features a curated collection of earlier OECD health content.
Health at a Glance Asia/Pacific 2020 analyses the impact of COVID-19 on the region’s health systems and government response measures to control the virus. It also reviews a set of key health indicators for 27 Asia-Pacific countries and territories.
Health at a Glance: Europe 2020 focuses on the impact of the COVID‑19 crisis. The pandemic has exposed the urgent need to consider the resilience of health systems as an equally important dimension of health system as accessibility, quality of care and efficiency.
How much do governments and citizens pay for drugs today? The high cost of new specialty drugs has led to accusations of profiteering by the pharmaceutical industry, generating debate about the industry-pricing model. With healthcare budgets under increasing pressure, the issue is set to remain in the political and public spotlight in the years ahead. Is a rise in pharmaceutical spending inevitable?
This new series brings together data, analysis and recommendations on a range of topics related to the impacts of the coronavirus (COVID-19) on health, healthcare systems and workers.
Discover other original data visualisations related to the COVID-19 crisis in Data Insights
This inventory pulls together OECD analysis and data on healthcare systems and workers. It covers topics both directly and indirectly related to many of the issues arising in the context of the global coronavirus (COVID-19) crisis, from the resilience of health systems to the public health threats caused by pandemics or fake pharmaceuticals,